DELENEX THERAPEUTICS

delenex-therapeutics-logo

Delenex Therapeutics AG is a Swiss biotech company developing therapeutic antibody fragments targeting serious medical diseases with high unmet need. The company's fragments are being designed for local/topical application by using the benefits of an antibody therapy with only limited systemic exposure. Its clinically validated technology delivers antibodies exhibiting the highest affinity, solubility and stability all combined with a very low risk of immunogenicity.

#SimilarOrganizations #People #Financial #Website #More

DELENEX THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Device Therapeutics

Founded:
2009-01-01

Address:
Zรผrich, Zurich, Switzerland

Country:
Switzerland

Website Url:
http://www.delenex.com

Total Employee:
1+

Status:
Active

Contact:
41 44 730 51 80

Total Funding:
41.3 M USD

Technology used in webpage:
SPF Amazon Amazon Frankfurt Region


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

levoss-logo

LevOss

LevOss is developing a biodegradable material (polymer) embedded with a Nano mesh.

panoptes-pharma-logo

Panoptes Pharma

Developing innovative small molecule drugs to treat eye diseases with high unmet medical need.

resistentia-pharmaceuticals-logo

Resistentia Pharmaceuticals

Resistentia Pharmaceuticals develops immunotherapeutic products for allergic asthma and inflammatory disorders.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.


Current Advisors List

thomas-dyrberg_image

Thomas Dyrberg Board of Directors @ Delenex Therapeutics
Board_member

Current Employees Featured

arnd-kaltofen_image

Arnd Kaltofen
Arnd Kaltofen Director @ Delenex Therapeutics
Director
2009-01-01

thomas-hecht_image

Thomas Hecht
Thomas Hecht Executive Chairman @ Delenex Therapeutics
Executive Chairman

Founder


dominik-escher_image

Dominik Escher

Investors List

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Venture Round - Delenex Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Delenex Therapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series A - Delenex Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series A - Delenex Therapeutics

vi-partners_image

VI Partners

VI Partners investment in Series A - Delenex Therapeutics

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series A - Delenex Therapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series A - Delenex Therapeutics

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series A - Delenex Therapeutics

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series A - Delenex Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series A - Delenex Therapeutics

Official Site Inspections

http://www.delenex.com

  • Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
  • IP address: 13.56.33.8
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Loading ...

More informations about "Delenex Therapeutics"

Delenex Therapeutics - Crunchbase Company Profile & Funding

Delenex Therapeutics AG is a Swiss biotech company developing therapeutic antibody fragments targeting serious medical diseases with high unmet need.See details»

Delenex - Company Profile - Tracxn

What are the most recent funding rounds of Delenex? Its latest funding round was a Series A round on Oct 29, 2013 for $8M. 5 investors participated in its latest round, which includes โ€ฆSee details»

Delenex Therapeutics - VentureRadar

"Delenex Therapeutics AG is a Swiss biotech company developing therapeutic antibody fragments targeting serious medical diseases with high unmet need.See details»

Delenex Therapeutics - PitchBook

When was Delenex Therapeutics founded? Delenex Therapeutics was founded in 2009. Where is Delenex Therapeutics headquartered? Delenex Therapeutics is headquartered in Zurich, โ€ฆSee details»

Delenex Therapeutics AG: Contact Details and Business Profile

Delenex was a privately held, clinical stage biopharmaceutical company focused on the development of locally and systemically applied antibody therapeutics.See details»

Delenex Therapeutics - Products, Competitors, Financials, โ€ฆ

Delenex is a biopharmaceutical company focused on the development of locally or topically applied antibody therapeutics. Use the CB Insights Platform to explore Delenex Therapeutics's โ€ฆSee details»

Cell Medica acquires Delenex Therapeutics - bionity.com

Jul 13, 2016 Cell Medica, a leader in developing, marketing and manufacturing cellular therapeutics for cancer and viral infections, announced today the acquisition of Delenex โ€ฆSee details»

Delenex Therapeutics - Crunchbase

Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.See details»

Organization | Delenex Therapeutics AG

Organization Overview. First Clinical Trial. 2012 NCT01595997. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2013 Timeline < Back; View all... NOW. Now; Active โ€ฆSee details»

Delenex Therapeutics AG - BioCentury Company Profiles - BCIQ

Delenex Therapeutics AG - BioCentury Company Profiles for the biopharma industrySee details»

Delenex completes its management team - Manufacturing Chemist

Swiss firm Delenex Therapeutics has appointed Thomas Jung as its chief medical officer. A board certified dermatologist, Jung has led research work in immunology at the Novartis Research โ€ฆSee details»

Home - Deletex nv

Deze website maakt gebruik van cookies De website van Deletex nv gebruikt functionele cookies. In het geval van het analyseren van websiteverkeer of advertenties, worden ook cookies โ€ฆSee details»

Delonex Energy - Org Chart, Teams, Culture & Jobs - The Org

View Delonex Energy's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Denex Inc - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Denex Inc of Varennes, QC. Get the latest business insights from Dun & Bradstreet.See details»

Matrix Organization: Definition, Benefits & Challenges | Ingentis

Feb 10, 2025 The matrix organization is a multidimensional organizational structure that combines elements of both functional and divisional organizations. In an era where companies โ€ฆSee details»

7 Organizational Structure Types (With Examples) โ€“ Forbes Advisor

May 29, 2024 A hierarchical organization structure is the pyramid-shaped organization chart many people are used to seeing. There is one role at the top of the pyramid and the chain of โ€ฆSee details»

Deletex Company Profile | Waregem, Belgium - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Deletex of Waregem. Get the latest business insights from Dun & Bradstreet. Deletex. D&B Business โ€ฆSee details»

Dealerex

Founded by a team of visionary leaders, Delarex Technologies thrives on creativity, excellence, and commitment. We specialize in providing comprehensive solutions across various sectors, โ€ฆSee details»

Home - Deletex nv

This website uses cookies The website of Deletex nv uses functional cookies. In case of analysing our traffic or advertising, we also place cookies that share information about your use of our โ€ฆSee details»

GitHub - bgwastu/deletex: Selectively delete your content on X ...

DeleteX uses PGLite as local storage to store your X archive data and the generated userscript. This means that your data is processed locally and never leaves your device. About. โ€ฆSee details»

linkstock.net © 2022. All rights reserved